If you have been wondering whether Johnson & Johnson is fairly priced or offering value right now, this article will walk ...

Johnson & Johnson (NYSE:JNJ) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. On February 3, RBC Capital raised its price target on Johnson & Johnson (NYSE:JNJ) to $255 from $240 ...

Johnson & Johnson (JNJ) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review ...

Johnson & Johnson (NYSE:JNJ) is one of the best long term low volatility stocks to invest in. On January 30, BofA lifted the ...

While it may not be a steal of a deal, with the business on the cusp of some exciting growth, Johnson & Johnson's stock could ...

Johnson & Johnson’s (NYSE: JNJ) stock price can continue to advance because its strategy to reinvigorate growth and widen margins is working. The plan centers on divesting underperforming healthcare ...

Johnson & Johnson (JNJ) stock gains as Morgan Stanley upgrades the company to Overweight, lifting the price target to $262, ...

Johnson & Johnson stock falls 1.7% despite beating Q4 earnings estimates with $2.46 EPS and strong 2026 guidance of $11.53 per share on $100.5B revenue.

After a strong performance in 2025, Johnson & Johnson is starting the new year right.

Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in combination with D-VRd. The regimen is approved for ...

Johnson & Johnson (NYSE: JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21. Analysts expect the company to report fourth-quarter earnings of $2.47 per ...